1. Carraway, R. & Leeman, S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248, 6854–6861 (1973)
2. Bissette, G., Nemeroff, C. B., Loosen, P. T., Prange, A. J., Jr & Lipton, M. A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature 262, 607–609 (1976)
3. Carraway, R. E. & Plona, A. M. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 27, 2445–2460 (2006)
4. Griebel, G. & Holsboer, F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nature Rev. Drug Discov. 11, 462–478 (2012)
5. Kitabgi, P. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Curr. Opin. Drug Discov. Devel. 5, 764–776 (2002)
6. Schimpff, R.-M. et al. Increased plasma neurotensin concentrations in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 70, 784–786 (2001)
7. Tanaka, K., Masu, M. & Nakanishi, S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4, 847–854 (1990)
8. Chalon, P. et al. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett. 386, 91–94 (1996)
9. Mazella, J. Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cell. Signal. 13, 1–6 (2001)
10. Barroso, S. et al. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. J. Biol. Chem. 275, 328–336 (2000)
11. Härterich, S., Koschatzky, S., Einsiedel, J. & Gmeiner, P. Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1. Bioorg. Med. Chem. 16, 9359–9368 (2008)
12. Pang, Y. P., Cusack, B., Groshan, K. & Richelson, E. Proposed ligand binding site of the transmembrane receptor for neurotensin8–13 . J. Biol. Chem. 271, 15060–15068 (1996)
13. Deupi, X. & Standfuss, J. Structural insights into agonist-induced activation of G-protein-coupled receptors. Curr. Opin. Struct. Biol. 21, 541–551 (2011)
14. Katritch, V., Cherezov, V. & Stevens, R. C. Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol. Sci. 33, 17–27 (2012)
15. Lebon, G., Warne, T. & Tate, C. G. Agonist-bound structures of G protein-coupled receptors. Curr. Opin. Struct. Biol. 22, 1–9 (2012)
16. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. & Schioth, H. B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256–1272 (2003)
17. Granier, S. et al. Structure of the δ-opioid receptor bound to naltrindole. Nature 485, 400–404 (2012)
18. Manglik, A. et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 485, 321–326 (2012)
19. Thompson, A. A. et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485, 395–399 (2012)
20. Wu, H. et al. Structure of the human κ-opioid receptor in complex with JDTic. Nature 485, 327–332 (2012)
21. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066–1071 (2010)
22. Choe, H. W. et al. Crystal structure of metarhodopsin II. Nature 471, 651–655 (2011)
